Compounded topical pain and scar creams have become one of the most prosecuted patterns in federal health care fraud enforcement. The Department of Justice has pursued both civil False Claims Act settlements and criminal health care fraud convictions against pharmacies, prescribers and marketers that billed TRICARE, Medicare Part D and the Department of Labor's workers' compensation program for formulations chosen to maximize reimbursement rather than to meet a documented medical need. For a compounding pharmacy, a single marketing arrangement or formulation decision can become the fact pattern a federal prosecutor builds a case around.
TRICARE Pain Cream Settlements
The Department of Justice announced a $21.36 million settlement with Diabetic Care Rx LLC, doing business as Patient Care America, two of its executives, and Riordan, Lewis & Haden Inc., the private equity firm that managed the pharmacy on behalf of its investors. The government alleged Patient Care America paid kickbacks to outside marketers to target military members and their families for prescriptions for compounded pain creams, scar creams and vitamins formulated to generate the highest possible reimbursement from TRICARE. The settlement resolved a civil False Claims Act lawsuit; no determination of liability was made.
A separate case produced criminal convictions. A federal jury convicted a podiatrist and a patient recruiter in April 2023, after prosecutors showed that between November 2014 and January 2017 the two caused a Fort Worth-based pharmacy to bill TRICARE approximately $8.5 million for compounded pain and scar creams the podiatrist prescribed to beneficiaries he had never examined.
Workers' Compensation Claims Draw a Larger Scheme
The Department of Labor's Office of Workers' Compensation Programs, which pays medical claims for injured federal employees, has also been a target. Nine defendants, including three pharmacy owners, a physician, two pharmacists and three patient recruiters, were sentenced for a multi-state scheme that billed the program and TRICARE roughly $126M. Prosecutors said the defendants chose compounded drugs based on reimbursement rather than documented medical need, paid kickbacks to the recruiters and physicians who generated the prescriptions, and mailed creams to patients who had never requested them. Sentences ranged from one year and six months to 20 years in prison.
Formulation Choices That Draw Scrutiny
Several of these prosecutions turn on the same underlying conduct: a formulation decision made for reimbursement rather than clinical reasons. Two Jacksonville, Florida pharmacies and their owner agreed to pay at least $7.4 million to resolve allegations that they added the oral antipsychotic aripiprazole to topical pain creams billed to Medicare Part D and TRICARE without an adequate clinical basis for the addition. The same scrutiny reaches a pharmacy that reformulates a product to resemble a commercially available drug; Compounding Copies of Commercially Available Drugs sets out the FDA test that separates a patient-specific modification from a reimbursement-driven one. A pharmacy operating under 503A/503B registration carries that documentation burden regardless of payer.
A compounded cream formulated to maximize reimbursement rather than to meet a documented medical need is the fact pattern that turns a routine audit into a federal fraud case.
Civil Settlements and Criminal Convictions Carry Different Exposure
The cases above split along a line that matters for any pharmacy under scrutiny. The civil False Claims Act, 31 U.S.C. § 3729, reaches a pharmacy or marketer that knowingly submitted or caused a false claim, where knowing includes actual knowledge, deliberate ignorance or reckless disregard; proof of intent to defraud is not required, and the statute resolves through a settlement and treble damages rather than a prison sentence. The criminal health care fraud statute, 18 U.S.C. § 1347, requires proof that the defendant knowingly and willfully executed a scheme to defraud a health care benefit program, and a conviction can carry prison time, as it did above. A pharmacy, prescriber or marketer tied to a compounded pain cream pattern can face both tracks at once.
Why Early Legal Counsel Is Critical
Compounding pharmacies, prescribers and marketers should retain healthcare defense counsel as soon as a subpoena, audit notice, investigative request or other government inquiry tied to compounded pain cream or scar cream billing arrives. Counsel can keep an inadvertent admission out of the response, preserve relevant defenses, and communicate with investigators on the provider's behalf.
Health Law Alliance has represented 2,500+ clients nationwide.
How Health Law Alliance Can Help
Health Law Alliance defends compounding pharmacies, prescribers and marketers facing civil False Claims Act exposure and criminal health care fraud charges tied to compounded pain cream and scar cream billing. If your pharmacy has received a subpoena, civil investigative demand or audit notice connected to TRICARE, Medicare Part D or workers' compensation billing for compounded drugs, contact us for a free, confidential consultation.
